Ste20-like kinase (SLK), a regulatory kinase for polo-like kinase (Plk) during the G2/M transition in somatic cells. 2000

H Ellinger-Ziegelbauer, and H Karasuyama, and E Yamada, and K Tsujikawa, and K Todokoro, and E Nishida
Department of Biophysics, Graduate School of Science, Kyoto University, Sakyo-ku, Kyoto 606-8502, Japan.

BACKGROUND Activation of the cyclin-dependent kinase cdc2-cyclin B1 at the G2/M transition of the cell cycle requires dephosphorylation of threonine-14 and tyrosine-15 in cdc2, which in higher eukaryotes is brought about by the Cdc25C phosphatase. In Xenopus, there is evidence that a kinase cascade comprised of xPlkk1 and Plx1, the Xenopus polo-like kinase 1, plays a key role in the activation of Cdc25C during oocyte maturation. In the mammalian somatic cell cycle, a polo-like kinase homologue (Plk1) also functions during mitosis, but a kinase upstream of Plk is still unknown. RESULTS We show here that human Ste20-like kinase (SLK), which is a ubiquitously expressed mammalian protein related to xPlkk1, can phosphorylate and activate murine Plk1. During progression through the G2 phase of the mammalian cell cycle, the activity of endogenous SLK is increased. The amount of SLK protein is decreased in quiescent and differentiating cells. Treatment with okadaic acid induces a phosphorylation-dependent enhancement of SLK activity. CONCLUSIONS We propose that SLK has a role in the regulation of Plk1 activity in actively dividing cells during the somatic cell cycle. SLK itself is suggested to be regulated by phosphorylation.

UI MeSH Term Description Entries
D008938 Mitosis A type of CELL NUCLEUS division by means of which the two daughter nuclei normally receive identical complements of the number of CHROMOSOMES of the somatic cells of the species. M Phase, Mitotic,Mitotic M Phase,M Phases, Mitotic,Mitoses,Mitotic M Phases,Phase, Mitotic M,Phases, Mitotic M
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011233 Precipitin Tests Serologic tests in which a positive reaction manifested by visible CHEMICAL PRECIPITATION occurs when a soluble ANTIGEN reacts with its precipitins, i.e., ANTIBODIES that can form a precipitate. Precipitin Test,Test, Precipitin,Tests, Precipitin
D011494 Protein Kinases A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein. Protein Kinase,Kinase, Protein,Kinases, Protein
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Ellinger-Ziegelbauer, and H Karasuyama, and E Yamada, and K Tsujikawa, and K Todokoro, and E Nishida
December 2005, The Journal of biological chemistry,
H Ellinger-Ziegelbauer, and H Karasuyama, and E Yamada, and K Tsujikawa, and K Todokoro, and E Nishida
February 2007, American journal of physiology. Renal physiology,
H Ellinger-Ziegelbauer, and H Karasuyama, and E Yamada, and K Tsujikawa, and K Todokoro, and E Nishida
January 2024, Physiological reports,
H Ellinger-Ziegelbauer, and H Karasuyama, and E Yamada, and K Tsujikawa, and K Todokoro, and E Nishida
July 2018, American journal of physiology. Renal physiology,
H Ellinger-Ziegelbauer, and H Karasuyama, and E Yamada, and K Tsujikawa, and K Todokoro, and E Nishida
October 2009, American journal of physiology. Renal physiology,
H Ellinger-Ziegelbauer, and H Karasuyama, and E Yamada, and K Tsujikawa, and K Todokoro, and E Nishida
August 2001, Cancer letters,
H Ellinger-Ziegelbauer, and H Karasuyama, and E Yamada, and K Tsujikawa, and K Todokoro, and E Nishida
May 2003, Proceedings of the National Academy of Sciences of the United States of America,
H Ellinger-Ziegelbauer, and H Karasuyama, and E Yamada, and K Tsujikawa, and K Todokoro, and E Nishida
July 2013, Skeletal muscle,
H Ellinger-Ziegelbauer, and H Karasuyama, and E Yamada, and K Tsujikawa, and K Todokoro, and E Nishida
September 2011, American journal of physiology. Renal physiology,
H Ellinger-Ziegelbauer, and H Karasuyama, and E Yamada, and K Tsujikawa, and K Todokoro, and E Nishida
November 2000, International journal of cancer,
Copied contents to your clipboard!